Bacterial dysentery - Symptoms, Causes, Treatment & Prevention

```html Bacterial Dysentery – Comprehensive Medical Guide

Bacterial Dysentery – Comprehensive Medical Guide

Overview

Bacterial dysentery is an infectious disease characterized by severe inflammation of the colon leading to frequent, watery‑to‑bloody stools. The condition is caused by invasive bacteria—most commonly Shigella species (shigellosis) or Salmonella (particularly S. enterica serovar Typhimurium), and occasionally Campylobacter or Enteroinvasive E. coli (EIEC). The term “dysentery” refers to the presence of blood and mucus in the stool, along with abdominal cramping and fever.

While dysentery can affect anyone, it is most prevalent in young children, travelers to low‑ and middle‑income countries, and people living in crowded or unsanitary conditions. According to the World Health Organization (WHO), an estimated 165 million cases of shigellosis occur each year worldwide, resulting in roughly 600,000 deaths, the majority of which are children under five in Sub‑Saharan Africa and South‑East Asia [1]. In the United States, the Centers for Disease Control and Prevention (CDC) reports ~500,000 shigellosis cases annually, with ~80% attributed to food‑borne outbreaks [2].

Symptoms

Symptoms typically appear 1–7 days after exposure (incubation period varies by organism). The severity ranges from mild, self‑limited illness to life‑threatening dehydration.

  • Frequent watery diarrhea – often the first sign.
  • Bloody stools – dark red or maroon, sometimes with visible mucus.
  • Abdominal cramping & pain – described as colicky or constant.
  • Fever – low‑grade (≤38 °C) to high (≥39 °C).
  • Nausea & vomiting – may precede diarrhea.
  • Urgency to defecate – sometimes with a feeling of incomplete evacuation.
  • Tenesmus – painful, continuous urge to pass stool despite an empty colon.
  • General malaise, headache, and muscle aches.
  • Dehydration signs – dry mouth, decreased urine output, dizziness, rapid heartbeat.

In children, symptoms may be less specific and can include irritability, poor feeding, and a sunken fontanelle.

Causes and Risk Factors

Primary bacterial agents

  • Shigella spp.S. sonnei, S. flexneri, S. dysenteriae, and S. boydii. Transmitted fecal‑orally via contaminated hands, food, water, or sexual contact.
  • Salmonella enterica (non‑typhoidal) – often from undercooked poultry, eggs, or contaminated produce.
  • Campylobacter jejuni – associated with raw poultry, unpasteurized milk.
  • Enteroinvasive E. coli (EIEC) – similar to Shigella in pathogenesis; acquired through contaminated food.

Risk factors

  • Travel to regions with poor sanitation (e.g., parts of Asia, Africa, Latin America).
  • Living in crowded settings such as refugee camps, prisons, or day‑care centers.
  • Young age – children <5 years have immature immune systems and higher exposure to contaminated surfaces.
  • Immunocompromised status – HIV/AIDS, chemotherapy, organ transplant recipients.
  • Recent antibiotic use – can select for resistant strains of Shigella or Salmonella.
  • Poor hand‑washing practices, especially after using the restroom or before handling food.
  • Sexual practices that involve fecal‑oral contact (e.g., anal intercourse).

Diagnosis

Accurate diagnosis requires a combination of clinical assessment and laboratory testing.

1. Clinical evaluation

  • History of exposure (travel, food, water, contact with sick individuals).
  • Physical exam focusing on abdominal tenderness, signs of dehydration, and fever.

2. Laboratory tests

  • Stool culture – Gold standard for identifying the bacterial species and for antimicrobial susceptibility testing. Sensitivity ~70‑80 %.
  • Polymerase chain reaction (PCR) panels – Multiplex assays detecting Shigella, Salmonella, Campylobacter, and other enteric pathogens with >90 % sensitivity, often faster than culture.
  • Stool antigen tests – Rapid immunoassays for Shigella; useful in low‑resource settings but less specific.
  • Fecal leukocytes & occult blood – Presence of white blood cells or blood supports invasive bacterial etiology.
  • Blood tests – CBC may show leukocytosis; electrolytes assess dehydration; CRP/ESR can indicate inflammation.

In severe cases, especially when sepsis is suspected, blood cultures may be performed.

Treatment Options

1. Rehydration – the cornerstone of therapy

  • Oral rehydration solution (ORS) – WHO‑recommended mixture of glucose, sodium, potassium, and citrate. Provides 75‑100 % of fluid loss in mild‑moderate cases.
  • Intravenous fluids – Indicated for severe dehydration, persistent vomiting, or shock. Typical regimen: 20 mL/kg bolus of isotonic saline, repeated as needed.

2. Antibiotic therapy

Antibiotics shorten the duration of symptoms and reduce transmission, but they should be used selectively because of growing resistance.

Preferred agents (based on resistance patterns)Dose & duration
Ciprofloxacin 500 mg PO BID3 days (adults); weight‑based dosing for children
Azithromycin 500 mg PO single doseCan be used for Shigella with fluoroquinolone resistance
Ceftriaxone 2 g IV dailyReserved for severe infection or resistant strains

For Salmonella non‑typhoidal infection, antibiotics are reserved for high‑risk patients (infants <3 months, immunocompromised, severe disease). Campylobacter is usually self‑limited; erythromycin or azithromycin may be used for severe cases.

3. Symptomatic relief

  • Anti‑motility agents (e.g., loperamide) are **contraindicated** in dysentery because they can retain toxin‑producing bacteria and worsen disease.
  • Acetaminophen for fever and pain (avoid NSAIDs if risk of GI bleeding).

4. Management of complications

  • Severe electrolyte imbalance – replace sodium, potassium, and bicarbonate as guided by labs.
  • Hemolytic‑uremic syndrome (HUS) from Shiga‑toxin‑producing strains – requires nephrology involvement, possible plasma exchange.

Living with Bacterial Dysentery

Most patients recover within 7‑10 days with proper care, but the illness can disrupt daily life. Practical tips:

  • Hydration schedule: Sip ORS or clear fluids (water, broths) every 15‑30 minutes. Aim for at least 2–3 L per day for adults.
  • Dietary considerations: Follow the “BRAT” diet (bananas, rice, applesauce, toast) during the acute phase, then gradually reintroduce low‑fat, low‑fiber foods. Avoid dairy, caffeine, alcohol, spicy or fried foods until stool normalizes.
  • Rest: Allow 2–3 days of reduced activity; avoid strenuous exercise until energy returns.
  • Hygiene: Wash hands with soap and water for at least 20 seconds after every bathroom visit and before meals. Use alcohol‑based hand sanitizer only when soap is unavailable.
  • Isolation: Stay home from work, school, or daycare for at least 48 hours after the last bloody stool to prevent spread.
  • Medication adherence: Complete the full antibiotic course even if symptoms improve.
  • Follow‑up: If symptoms persist beyond 5 days, or if dehydration recurs, contact a healthcare provider.

Prevention

Prevention focuses on interrupting fecal‑oral transmission.

  • Safe water: Drink only treated water (boiled ≥1 min, filtered, or chemically disinfected). Use bottled water in high‑risk travel areas.
  • Food safety: Cook meats to an internal temperature of 165 °F (74 °C); avoid raw or undercooked eggs, unpasteurized dairy, and raw sprouts.
  • Hand hygiene: Wash hands with soap after using the toilet, changing diapers, and before preparing food.
  • Sanitation: Ensure proper disposal of human waste; use latrines with hand‑washing stations.
  • Travel precautions: Use bottled beverages, peel fruits yourself, avoid street‑food salads, and carry ORS packets.
  • Vaccines (under investigation): Several Shigella vaccine candidates are in Phase 2/3 trials; none are commercially available yet.
  • Antibiotic stewardship: Avoid unnecessary antibiotics to limit resistance development.

Complications

When left untreated or in high‑risk patients, bacterial dysentery can lead to serious complications:

  • Severe dehydration – electrolyte imbalance, acute kidney injury.
  • Hemolytic‑uremic syndrome (HUS) – especially with Shiga‑toxin–producing S. dysenteriae. Presents with anemia, thrombocytopenia, and renal failure.
  • Reactive arthritis – sterile joint inflammation occurring 1–3 weeks after infection; more common after Shigella.
  • Sepsis – systemic inflammatory response leading to organ dysfunction.
  • Chronic carrier state – some individuals may harbor Shigella in the colon for weeks, serving as a reservoir for transmission.
  • Long‑term growth faltering in children due to repeated episodes and malnutrition.

When to Seek Emergency Care

Call 911 or go to the nearest emergency department if you notice any of the following:

  • Signs of severe dehydration: dry mouth, no tears when crying (children), dizziness, rapid heartbeat, low blood pressure, or fainting.
  • Persistent high fever > 39.5 °C (103 °F) despite antipyretics.
  • Blood in stool accompanied by black, tarry stools (possible upper GI bleed).
  • Severe abdominal pain with guarding or rebound tenderness (possible perforation).
  • Vomiting that prevents keeping any fluids down for > 12 hours.
  • Neurological symptoms: confusion, seizures, or severe headache.
  • Rapid heart rate (> 120 bpm) or breathing difficulty.
  • Signs of hemolytic‑uremic syndrome: reduced urine output, swollen legs, pink‑red rash, or bruising.

Early intervention can prevent life‑threatening complications.

References

  1. World Health Organization. “Shigella.” WHO Fact Sheets, 2022. https://www.who.int/news-room/fact-sheets/detail/shigella
  2. Centers for Disease Control and Prevention. “Shigellosis (Shigella Infection).” CDC, 2023. https://www.cdc.gov/shigella/index.html
  3. Mayo Clinic. “Dysentery.” Mayo Clinic, 2024. https://www.mayoclinic.org/diseases-conditions/dysentery/symptoms-causes/syc-20371999
  4. Cleveland Clinic. “Shigellosis (Shigella Infection).” 2023. https://my.clevelandclinic.org/health/diseases/21055-shigellosis
  5. National Institutes of Health. “Antibiotic Treatment of Acute Bacterial Gastroenteritis.” NIH Clinical Guidelines, 2022.
  6. WHO. “Oral Rehydration Salts (ORS) – Preparation & Use.” 2021. https://www.who.int/health-topics/oral-rehydration-solution
```

⚠️ Medical Disclaimer

Important: The information provided on this page is for general informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

If you think you may have a medical emergency, call your doctor, go to the emergency department, or call 911 immediately.